Immature mast cells exhibit rolling and adhesion to endothelial cells and subsequent diapedesis triggered by E- and P-selectin, VCAM-1 and PECAM-1

Experimental Dermatology

Volumn 19, Issue 5, 2010, Pages 424-434

  Dudeck, Anne ^a,b   Leist, Mandy ^a   Rubant, Simone ^c   Zimmermann, Anja ^a   Dudeck, Jan ^b   Boehncke, Wolf Henning ^c   Maurer, Marcus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Adhesion molecules; Endothelial cells; Extravasation; Inflammation; Mast cells

Indexed keywords

CD31 ANTIGEN; CD51 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 15; INTERLEUKIN 4; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL WALL; CELL ADHESION; CELL CONTACT; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROTEIN FUNCTION; SKIN BLOOD VESSEL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; CELL ADHESION; CELL LINE, TRANSFORMED; CELL MOVEMENT; E-SELECTIN; ENDOTHELIAL CELLS; INTEGRIN ALPHA4BETA1; INTEGRIN ALPHAVBETA3; INTEGRINS; INTERLEUKIN-15; INTERLEUKIN-4; MAST CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; P-SELECTIN; SELECTINS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953141940     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01073.x     Document Type: Article

References (75)

1. Metcalfe D D, Baram D, Mekori Y A. Mast cells. Physiol Rev 1997, 77:1033-1079.
2. Kalesnikoff J, Galli S J. New developments in mast cell biology. Nat Immunol Rev 2008, 9:1215-1223.
3. Galli S J, Maurer M, Lantz C S. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999, 1:53-59.
4. Metz M, Grimbaldeston M A, Nakae S, Piliponsky A M, Tsai M, Galli S J. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007, 217:304-328.
5. Kneilling M, Röcken M. Mast cells: novel clinical perspectives from recent insights. Exp Dermatol 2009, 18:488-496.
6. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978, 52:447-452.
7. Kitamura Y, Ito A. Mast cell-committed progenitors. Proc Natl Acad Sci USA 2005, 102:11129-11130.
8. Kitamura Y, Oboki K, Ito A. Molecular mechanism of mast cell development. Immunol Allergy Clin North Am 2006, 26:387-405.
9. Denburg J A. Bone marrow in atopy and asthma: haematopoietic mechanisms in allergic inflammation. Immunol Today 1999, 20:111-113.
10. Okayama Y, Kawakami T. Development, migration and survival of mast cells. Immunol Res 2006, 34:97-115.
11. Hallgren J, Gurish M F. Pathways of murine mast cell development and trafficking: tracking the roots and routes of the mast cell. Immunol Rev 2007, 217:8-18.
12. Gurish M F, Boyce J A. Mast cells: Ontogeny, homing, and recruitment of a unique innate effector cell. J Allergy Clin Immunol 2006, 117:1285-1291.
13. Yang F-C, Chen S, Clegg T. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-β signalling. Hum Mol Genet 2006, 5:2421-2437.
14. Gottfried O N, Viskochil D H, Fults D W, Couldwell W T. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery 2006, 58:1-16.
15. Diaconu N-C, Kaminutesska R, Naukkarinen A, Harvima R J, Nilsson G, Harvima I T. Increase in CD30 ligand/CD153 and TNF-α expressing mast cells in basal cell carcinoma. Cancer Immunol Immunother 2007, 56:1407-1415.
16. Ch'ng S, Sullivan M, Yuan L, Davis P, Tan S T. Mast cells dysregulate apoptotic and cell cycle genes in mucosal squamous cell carcinoma. Cancer Cell Int 2006, 6:28.
17. Caruso R A, Fedele F, Zuccalà V, Fracassi M G, Venuti A. Mast cell and eosinophil interaction in gastric carcinomas: ultrastructural observations. Anticancer Res 2007, 27:391-394.
18. Gotis-Graham I, Smith M D, Parker A, McNeil H P. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann Rheum Dis 1998, 57:664-671.
19. Eklund K K. Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy. Immunol Rev 2007, 217:38-52.
20. Seibold J R, Giorno R C, Claman H N. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990, 33:1702-1729.
21. Boyce J A. Mast cells: beyond IgE. J Allergy Clin Immunol 2003, 111:24-32.
22. Brithling C E, Bradding P, Symon F A, Holgate S T, Wardlaw A J, Pavord I D. Mast cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002, 346:1699-1705.
23. Carroll N G, Mutavdzic S, James A L. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 2002, 19:879-885.
24. Nibbs J B, Gilchrist D S, King V. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest 2007, 117:1884-1892.
25. Lee D M, Friend D S, Gurish M F, Benoist C, Mathis D, Brenner M. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692.
26. Wang W H, Tedla N, Hunt N E, Wakefield D, McNeil H P. Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma. Exp Dermatol 2005, 14:295-302.
27. Ikeda R K, Miller M, Nayar J. Accumulation of peribronchial mast cells in a mouse model of ovalbumine allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J Immunol 2003, 171:4860-4867.
28. Gurish M F, Boyce J A. Mast cell growth, differentiation, and death. Clin Rev Allergy Immunol 2002, 22:107-118.
29. Pendl G G, Robert C, Steinert M. Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. Blood 2002, 99:946-956.
30. Grimbaldeston M A, Nakae S, Kalesnikoff J, Tsai M, Galli S J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007, 8:1095-1104.
31. Wetzel A, Chavakis T, Preissner K T. Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Immunol 2004, 172:3850-3859.
32. Rubant S A, Ludwig R J, Diehl S. Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression. J Invest Dermatol 2008, 128:326-331.
33. Ludwig R J, Schultz J E, Boehncke W H. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004, 122:830-836.
34. Rüster B, Göttig S, Ludwig R J. Mesenchymal stem cells display coordinated rolling and adhesion behaviour on endothelial cells. Blood 2006, 108:3938-3944.
35. Alban S, Ludwig R J, Bendas G. PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions. J Invest Dermatol 2009, 129:1192-202.
36. Oostingh G J, Pozgajova M, Ludwig R J. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. Haematologica 2007, 92:502-512.
37. Schön M P, Krahn T, Schön M. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med 2002, 8:366-372.
38. Nilsson G, Mikovits J, Metcalfe D D, Taub D D. Mast cell migratory response to IL-8 is mediated through interaction with chemokine receptor CXC-2/IL-8RB. Blood 1999, 93:2791-2797.
39. Lippert U, Artuc M, Grützkau A. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol 1998, 161:2600-2608.
40. Brightling C E, Ammit A J, Kaur D. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005, 171:1103-1108.
41. Lin T-J, Issekutz T B, Marshall J S. SDF-1 induces IL-8 production and transendothelial migration of human cord blood derived mast cells. Int Arch Allergy Immunol 2001, 124:142-145.
42. Juremalm M, Hjertson M, Olsson N, Harvima I, Nilsson K, Nilsson G. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1α acts as a mast cell chemotaxin. Eur J Immunol 2000, 30:3614-3622.
43. Juremalm M, Olsson N, Nilsson G. Selective CCL-5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 2002, 297:480-485.
44. Abonia J P, Austen K F, Rollins B J. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood 2005, 105:4308-4313.
45. Humbles A A, Lu B, Friend D S. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci USA 2002, 99:1479-1484.
46. Olsson N, Taub D D, Nilsson G. Regulation of mast cell migration by TH1 and TH2 cytokines: identification of tumour necrosis factor-α and interleukin-4 as mast cells chemotaxins. Scand J Immunol 2004, 59:267-272.
47. Ghebrehiwet B, Kew R R, Gruber B L, Marchese M J, Peerschke E I B, Reid K B M. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. J Immunol 1995, 155:2614-2619.
48. Hartmann K, Henz B M, Krüger-Krasagakes S. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997, 89:2863-2870.
49. Nilsson G, Johnell M, Hammer C H. C3a and C5a are chemotaxins for mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 1996, 157:1693-1698.
50. Meininger C J, Yano H, Rottapel R, Bernstein A, Zsebo K M, Zetter B R. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992, 79:958-963.
51. Nilsson G, Butterfield J H, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994, 153:3717-3723.
52. Gruber B L, Marchese M J, Kew R R. Transforming growth factor-β1 mediates mast cell chemotaxis. J Immunol 1994, 152:5860-5867.
53. Olsson N, Piek E, ten Dijke P, Nilsson G. Mast cell migration in response to members of the TGF-β family. J Leukoc Biol 2000, 67:350-356.
54. Conti P, Reale M, Barbacane R C, Letourneau R, Theoharides T C. Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell-deficient W/WV mice. FASEB J 1998, 2:1693-1700.
55. Fischer M, Juremalm M, Olsson N. Expression of CCL5/Rantes by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int J Cancer 2003, 107:197-201.
56. Taub D, Dastych J, Inamura N. Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 1995, 154:2393-2402.
57. El-Shazly A, Berger P, Girodet P-O. Fractalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol 2006, 176:1860-1868.
58. Papadopoulos E J, Fitzhugh D J, Tkaczyk C. Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol 2000, 30:2355-2361.
59. Matsuura N, Zetter B R. Stimulation of mast cells chemotaxis by interleukin 3. J Exp Med 1989, 170:1421-1426.
60. Jackson N E, Wang H-W, Tedla N. IL-15 induces mast cell migration via a pertussis toxin-sensitive receptor. Eur J Immunol 2005, 35:2376-2385.
61. Nilsson G, Metcalfe D D, Taub D D. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology 2000, 99:314-319.
62. Romagnani P, De Paulis A, Beltrame C. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 1999, 155:1195-1204.
63. Weller C L, Collington S J, Brown J K. Leukotrien B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med 2005, 201:1961-1971.
64. Gurish M F, Tao H, Abonia J P. Intestinal mast cell progenitors require CD49dβ7 (α4β7 integrin) for tissue-specific homing. J Exp Med 2001, 94:1243-1252.
65. Grimbaldeston M A, Chen C-C, Piliponsky A M, Tsai M, Tam S-Y, Galli S J. Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005, 167:835-848.
66. Kneilling M, Mailhammer R, Hültner L. Direct crosstalk between mast cell TNF and TNFR1-expressing endohtelia meidates local tissue inflammation. Blood 2009, 114:1696-1706.
67. Boyce J A, Mellor E A, Perkins B, Lim Y-C, Luscinskas F W. Human mast cell progenitors use a4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions. Blood 2002, 99:2890-2896.
68. Gonzalez-Amaro R, Sanchez-Madrid F. Cell adhesion molecules: selectins and integrins. Crit Rev Immunol 1999, 19:389-429.
69. Oppenheimer-Marks N, Davis L S, Bogue D T, Ramberg J, Lipsky P E. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 1991, 147:2913-2921.
70. Su W-H, Chen H I, Jen C J. Differential movements of VE-Cadherin and PECAM-1 during transmigration of polymorphonuclear leukocytes through human umbilical vein endothelium. Blood 2002, 100:3597-3603.
71. Romer L H, McLean N V, Yan H C, Daise M, Sun J, DeLisser H M. IFN-γ and TNF-α induce redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol 1995, 154:6582-6592.
72. Marelli-Berg F M, Nourshargh S. Mechanisms of leukocyte transmigration: role of immunoglobulin superfamily molecules. Leukocyte Trafficking 2005, 82-95. Hamann A, Engelhardt B. In, eds, Weinheim, WILEY-VCH Verlag GmbH & Co
73. Petri B, Bixel M G. Molecular events during leukocyte diapedesis. FEBS J 2006, 273:4399-4407.
74. Chiba R, Nakagawa N, Kurasaw K, Tanaka Y, Saito Y, Iwamoto I. Ligation of CD31 (PECAM-1) on endothelial cells increases adhesive function of alphavbeta3 integrin and enhances beta1 integrin-mediated adhesion of eosinophils to endothelial cells. Blood 1999, 94:1319-1329.
75. Rainger G E, Buckley C D, Simmons D L, Nash G B. Neutrophils sense flow-generated stress and direct their migration through alphaVbeta3-integrin. Am J Pathol 1999, 276:H858-H864.